Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. - Wikidata - awgldk - TriplyDB

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

http://www.wikidata.org/entity/Q43861367

about

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?Interventions for enhancing medication adherence Interventions for enhancing medication adherence A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk Etiology and outcome of acute gastrointestinal bleeding in iran:a review article Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy NSAIDs: gastroprotection or selective COX-2 inhibitor?Current state of therapy for pain and inflammation Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Guidelines for prevention of NSAID-related ulcer complications.NSAIDs.Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity Prevention of chronic NSAID induced upper gastrointestinal toxicity.A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.An evidence-based update on nonsteroidal anti-inflammatory drugs.Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.The Pattern of Use of Oral NSAIDs with or without Co-prescription of Gastroprotective Agent for Arthritic Knee by Korean Practitioners Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled tria Non-steroidal Anti-inflammatory Drugs (NSAIDs) Use in Primary Health Care Centers in A'Seeb, Muscat: A Clinical Audit.Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.NSAIDs and gastrointestinal complications: new clinical challenges.Review article: acid-related disease--what are the unmet clinical needs?Review article: the opportunities and benefits of extended acid suppression.Cardiovascular risks of cyclooxygenase inhibition.

P2860

Q22306448-3A7B8300-F540-440A-B145-AE5925DA966F Q24187912-BAE85826-B803-4097-AE57-7A8CFC670472 Q24243296-268F899C-7070-4700-9732-032F8944941C Q24615651-C134083A-DED2-41D7-9EC7-FFD4CC7A3A86 Q26864640-BF746556-0E89-4D1A-9DFD-4187157A1A2E Q27023609-8B3B3D9B-E26B-40E7-A240-676E06BD2D7B Q27304750-C9667D33-940D-42A9-8F06-9AFF4FE1EC8C Q28166768-55D94692-ADC8-49E8-A90C-A8AB575005EE Q28168965-5FA4B358-E035-4AD5-BF2C-F6BEC8DA5C3E Q28191916-F54FE52A-4E52-4837-910E-67324CC89B8F Q28191928-0E00A8DB-2853-4C12-9989-19C1BB43ABF1 Q28195079-1F67D09D-BC0D-4080-9865-2F35CD6773D4 Q28200571-707DF6D0-F768-4D79-A07C-F4FBB78BDB9B Q28201393-1EE369A8-7402-470D-BE78-E3853B57E76F Q28210656-B46873FF-1179-4C18-8655-7A038BCEEA27 Q28218734-84A7CC3B-4EF9-43B1-B6E7-33D36BD9C48B Q28218738-6B54D876-2D71-4666-9181-C20C768F0BEA Q30415171-FA148016-647D-4CFB-9730-C2909C6E55E0 Q30457290-7E044884-93BC-4B50-A0A8-29D4DA54ED50 Q33412100-0D131D96-6931-4028-8A55-78CA257047FB Q33448171-58103BCC-63FD-42CE-9D1E-CB1A44FA18A3 Q33678007-B51F3050-8688-40AC-AACC-FD8DDAED592B Q33959603-9EBA738D-A811-45DF-B593-E62C9C9E9C53 Q33978682-3793716F-B992-43B8-AD9B-A87D7A419677 Q34250591-5136698F-8AD2-43B8-AAB4-AA72AEEAD8A1 Q35058190-98A416AF-815A-46C9-AF1B-9DB6C1BF6098 Q35106649-42206685-51DA-40DB-A10C-9EC5008E327D Q35158795-DB94A1E0-F40B-4EAD-85B0-B2D869758619 Q35758411-FB379570-C9EB-4486-8485-5B4871A2A87C Q35814862-93D59D16-8870-4684-8049-901D44D29708 Q35845845-29D6E05C-61AA-463C-93D7-52101C1E9543 Q35926946-4BD78737-0C3E-4DCE-8E70-ECEB079B0BE1 Q35989849-E5F9ACFE-A58E-4269-B146-F944B1C7610E Q36076845-773A0D78-C99D-43A7-B680-69F54BB31A4E Q36246550-6EF7F70F-BB6D-4BF4-A403-0A4E1A2232A1 Q36319521-E595C6A6-2FF0-40CB-9B31-AA2DDFD0DF11 Q36326243-3705E7D5-ED53-4199-B9BA-B6204AE013D6 Q36478873-4D524862-A45D-4F96-905A-B3B69521DC86 Q36478875-6562BA31-E952-4F0C-A7D3-7A5B3F85C798 Q36520638-EFA97198-81E8-488A-BF51-C48FEDA5A50A

P2860

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

http://www.wikidata.org/entity/Q43861367

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@en

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@nl

type

label

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@en

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@nl

prefLabel

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@en

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@nl

P1433

Q43861367-552A7420-A00A-4FA9-96CB-D3F238F4EF06

P1476

Q43861367-DB14450A-AE1F-40B7-B2B3-563C16F4BEAA

P2093

Q43861367-28BB6DDE-049C-4D52-B85F-45695FD6FD98

Q43861367-8A8CD8D1-9002-4C78-8FA1-C87DA256C0E1

Q43861367-A875ED13-6D5E-48C0-B728-6D00E66D9730

Q43861367-AF06A9E6-493B-41F3-B0DB-24511D27C384

Q43861367-B7E9A077-2863-4116-8C04-70D277B11082

Q43861367-C8706920-2768-4380-AC4E-7C5CEF2D7141

Q43861367-CE0B7E0A-51D3-4AD8-B00D-121B1ADD0219

Q43861367-F604B93E-90EF-4033-B1C2-08308656E74B

P304

Q43861367-EED5421E-02AB-4158-84C3-87382A97A338

P31

Q43861367-A74F0E90-ED8E-4BBA-BE70-7DE6FB3D8813

P356

Q43861367-AE5F1EE4-A7D5-4EDA-9E5F-1B5F8EC34CB3

P407

Q43861367-3B38F853-7A50-45B4-AB64-66DE0814F5B6

P433

Q43861367-B44409EC-C6C2-425B-80FB-CE8389D8ABF4

P478

Q43861367-DE75C942-A1E1-42ED-B4B8-079A560886AC

P577

Q43861367-CBBCF9B4-CC06-42F0-98F9-C01460511B03

P5875

Q43861367-E88A6C92-02FE-40AE-9C55-B65A5716E06B

P698

Q43861367-A47AD396-9DBE-4AE0-8EDF-E2B47793323B

P921

Q43861367-224AE0C0-0375-4BAD-86E7-714FB2C005AD

P356

ARCHINTE.162.2.169

P1433

JAMA Internal Medicine

P1476

Ulcer prevention in long-term ...... f misoprostol vs lansoprazole.

@en

P2093

Bidan Huang

http://www.w3.org/2001/XMLSchema#string

Cyndy Collis

http://www.w3.org/2001/XMLSchema#string

David Y Graham

http://www.w3.org/2001/XMLSchema#string

Donald R Campbell

http://www.w3.org/2001/XMLSchema#string

Marian M Haber

http://www.w3.org/2001/XMLSchema#string

NSAID-Associated Gastric Ulcer Prevention Study Group

http://www.w3.org/2001/XMLSchema#string

Nancy L Lukasik

http://www.w3.org/2001/XMLSchema#string

Naurang M Agrawal

http://www.w3.org/2001/XMLSchema#string

P304

169-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.162.2.169

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11555859

http://www.w3.org/2001/XMLSchema#string

P698

11802750

http://www.w3.org/2001/XMLSchema#string

P921